{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:37:58Z","timestamp":1762979878207},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.canep.2011.05.016","type":"journal-article","created":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T03:23:38Z","timestamp":1332300218000},"page":"133-136","source":"Crossref","is-referenced-by-count":8,"title":["Recent decline in the U.S. death rate from myeloproliferative neoplasms, 1999\u20132006"],"prefix":"10.1016","volume":"36","author":[{"given":"Anthony P.","family":"Polednak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2011.05.016_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3322\/caac.20009","article-title":"Advances in understanding and management of myeloproliferative neoplasms","volume":"59","author":"Vannucchi","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canep.2011.05.016_bib0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canep.2011.05.016_bib0015","series-title":"SEER cancer statistics review 1975\u20132007","year":"2010"},{"key":"10.1016\/j.canep.2011.05.016_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2008-01-134858","article-title":"Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001\u20132004, using data from the NAAACR and SEER programs","volume":"112","author":"Rollison","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canep.2011.05.016_bib0025","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s002779900136","article-title":"Myeloproliferative disorders: Complications, survival and causes of death","volume":"79","author":"Brodmann","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.canep.2011.05.016_bib0030","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: The natural history of 1213 patients followed for 20 years","volume":"123","author":"Gruppo Italiano Studio Policitemia","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.canep.2011.05.016_bib0035","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","article-title":"et al. Vascular and neoplastic risk in a large cohort of patients with polycythemia","volume":"23","author":"Marchioli","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canep.2011.05.016_bib0040","series-title":"Hematology basic principles and practice","author":"Hoffman","year":"2008"},{"key":"10.1016\/j.canep.2011.05.016_bib0045","year":"2008","journal-title":"Informa. Healthcare"},{"key":"10.1016\/j.canep.2011.05.016_bib0050","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1001\/jama.283.22.2975","article-title":"Are increasing 5-year survival rates evidence of success against cancer?","volume":"283","author":"Welch","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2011.05.016_bib0055","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/aje\/136.7.855","article-title":"Use of multiple-cause mortality data in epidemiologic analyses: US rate and proportion files developed by the National Institute for Occupational Safety and Health and the National Cancer Institute","volume":"136","author":"SteenlandK","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.canep.2011.05.016_bib0060","unstructured":"Centers for Disease Control and Prevention. National Center for Health Statistics. Multiple cause of death file 2005\u20132006. CDC WONDER on-line database, compiled from multiple cause of death file 2005\u20132006 Series 20 No. 2L, 2009. http:\/\/wonder.cdc.gov\/mcd-icd10.html."},{"key":"10.1016\/j.canep.2011.05.016_bib0065","unstructured":"National Cancer Institute. Surveillance, Epidemiology and End Results Program. Faststats. http:\/\/www.seer.cancer.gov."},{"key":"10.1016\/j.canep.2011.05.016_bib0070","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2010.03.018","article-title":"Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia","volume":"123","author":"Wiggins","year":"2010","journal-title":"Amer J Med"},{"key":"10.1016\/j.canep.2011.05.016_bib0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.7326\/0003-4819-152-5-201003020-00008","article-title":"Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations:The phenotypic mimicry of chronic myeloproliferation","volume":"152","author":"Spivak","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.canep.2011.05.016_bib0080","first-page":"2513","article-title":"Primary myelofibrosis and the myeloproliferative neoplasms","volume":"303","author":"Stein","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canep.2011.05.016_bib0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/asheducation-2010.1.129","article-title":"Rethinking disease definitions and therapeutic strategies in essential thrombocythemia and polycythemia vera","author":"Harrison","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.canep.2011.05.016_bib0090","first-page":"e21","article-title":"Heart disease and stroke statistics \u2013 2009update","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.canep.2011.05.016_bib0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.amepre.2010.05.009","article-title":"Coronary mortality declines in the U.S. between 1980 and 2000: Quantifying the contributions from primary and secondary prevention","volume":"39","author":"Young","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.canep.2011.05.016_bib0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.blre.2010.08.002","article-title":"Thrombohemorrhagic complications of myelo-proliferative disorders","volume":"24","author":"Papadakis","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.canep.2011.05.016_bib0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11606-006-0019-x","article-title":"The impact of venous thromboembolisms on risk of death or hemorrhage in older cancer patients","volume":"22","author":"Gross","year":"2007","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.canep.2011.05.016_bib0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11739-009-0319-3","article-title":"Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential thrombocythemia","volume":"5","author":"Vannucchi","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.canep.2011.05.016_bib0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythemia vera","volume":"350","author":"Landolphi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canep.2011.05.016_bib0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canep.2010.09.005","article-title":"The accuracy of cancer mortality statistics based on death certificates in the United States","volume":"35","author":"German","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.canep.2011.05.016_bib0125","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/cc5782","article-title":"Premortem clinical diagnoses and postmortem autopsy findings: Discrepancies in critically ill cancer patients","volume":"11","author":"Pastores","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.canep.2011.05.016_bib0130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00277-008-0461-4","article-title":"Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera","volume":"87","author":"Swolin","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.canep.2011.05.016_bib0135","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.exphem.2009.06.006","article-title":"JAK2V617F allele burden and thrombosis: A direct comparison in essential thrombocythemia and polycythemia vera","volume":"37","author":"Carobbio","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.canep.2011.05.016_bib0140","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","article-title":"Thrombosis in primary myelofibrosis: Incidence and risk factors","volume":"115","author":"Barbui","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canep.2011.05.016_bib0145","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/sj.bjc.6601633","article-title":"Trend in mortality for cancers, comparing multiple- and underlying cause rates, in an English population 1979\u20131999","volume":"90","author":"Goldacre","year":"2004","journal-title":"Br J Cancer"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782111000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782111000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T02:59:25Z","timestamp":1543114765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782111000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1877782111000981"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2011.05.016","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}